MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer
Open Access
- 23 February 2023
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 10 (12)
Abstract
Tamoxifen is commonly used for the treatment of patients with estrogen receptor‐positive (ER+) breast cancer, but the acquired resistance to tamoxifen presents a critical challenge of breast cancer therapeutics. Recently, long noncoding RNA MIR497HG and its embedded miR‐497 and miR‐195 are proved to play significant roles in many types of human cancers, but their roles in tamoxifen‐resistant breast cancer remain unknown. The results indicate that MIR497HG deficiency induces breast cancer progression and tamoxifen resistance by inducing downregulation of miR‐497/195. miR‐497/195 coordinately represses five positive PI3K‐AKT regulators (MAP2K1, AKT3, BCL2, RAF1, and CCND1), resulting in inhibition of PI3K‐AKT signaling, and PI3K‐AKT inhibition in tamoxifen‐resistant cells restored tamoxifen responsiveness. Furthermore, ER α binds the MIR497HG promoter to activate its transcription in an estrogen‐dependent manner. ZEB1 interacts with HDAC1/2 and DNMT3B at the MIR497HG promoter, resulting in promoter hypermethylation and histone deacetylation. The findings reveal that ZEB1‐induced MIR497HG depletion contributes to breast cancer progression and tamoxifen resistance through PI3K‐AKT signaling. MIR497HG can be used as a biomarker for predicting tamoxifen sensitivity in patients with ER+ breast cancer.Keywords
Funding Information
- National Natural Science Foundation of China (82172827, 81502518, 82172835)
This publication has 50 references indexed in Scilit:
- Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patientsGene, 2019
- miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial–mesenchymal transitionMolecular Cancer, 2018
- lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signalingNature Medicine, 2017
- ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancerCell Death & Disease, 2017
- Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in gliomaNeuro-Oncology, 2017
- SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497Molecular Therapy, 2016
- Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancerGut, 2011
- Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast CancerClinical Cancer Research, 2011
- Diverse Gene Expression and DNA Methylation Profiles Correlate with Differential Adaptation of Breast Cancer Cells to the Antiestrogens Tamoxifen and FulvestrantCancer Research, 2006
- Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to TamoxifenCancer Research, 2004